Medikine
1 known investors
Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology. The company develops optimized therapies based on cytokine mimesis for clinical use.
Founders & leadership
WJ
William J. DowerPhD
MC
Michael C. NeedelsPhD
RW
Ronald W. BarrettPhD
JL
Joseph LevequeMD, CEO